RIL
AVBP icon

Rothschild Investment LLC’s ArriVent BioPharma AVBP Stock Holding History

Rothschild Investment LLC’s Portfolio AVBP Stock Details AVBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$799 Hold
23
– – ﹤0.01% 3130
2026
Q1 		$531 Buy
23
+3
+15% +$68 ﹤0.01% 3109
2025
Q4 		$402 Hold
20
– – ﹤0.01% 2978
2025
Q3 		$369 Hold
20
– – ﹤0.01% 2894
2025
Q2 		$435 Sell
20
-50
-71% -$1.04K ﹤0.01% 2789
2025
Q1 		$1.29K Buy
70
+25
+56% +$612 ﹤0.01% 2187
2024
Q4 		$1.2K Buy
45
+35
+350% +$1K ﹤0.01% 2101
2024
Q3 		$235 Buy
10
+5
+100% +$113 ﹤0.01% 2679
2024
Q2 		$93 Buy
+5
New +$89 ﹤0.01% 2751

Other funds holding AVBP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
EA
Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return

Rothschild Investment LLC's AVBP Position: Q2 2026 in Review

Rothschild Investment LLC held its ArriVent BioPharma (AVBP) position steady in Q2 2026 at 23 shares worth $799. The position accounts for ﹤0.01% of the portfolio, ranked #3130.

Rothschild Investment LLC first reported a position in AVBP in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.29K in Q1 2025. 41 funds tracked by Wall St. Rank hold AVBP as of Q2 2026.

  • Rothschild Investment LLC held 23 shares of ArriVent BioPharma worth $799 as of Q2 2026.
  • Rothschild Investment LLC left its ArriVent BioPharma share count unchanged in Q2 2026.
  • ArriVent BioPharma made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #3130 holding.
  • Rothschild Investment LLC first reported a position in ArriVent BioPharma in Q2 2024 and has held it in 9 quarters since.
  • Rothschild Investment LLC's ArriVent BioPharma position peaked at $1.29K in Q1 2025.
  • 41 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.